The race between COVID-19 vaccines and variants continues despite concern about efficacy

South Africa has halted its rollout of the AstraZeneca COVID-19 vaccine after a study showed it offered minimal protection against mild infection from a variant spreading there. While experts say it's cause for concern, they say vaccines can be reconfigured to protect against mutations.